Strateos

Strateos

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $86M

Overview

Strateos has pioneered the concept of the 'cloud lab' or 'remote-access automated laboratory,' a platform that allows scientists to design, execute, and analyze experiments entirely through a software interface. Its technology integrates laboratory robotics, instrumentation, and data management into a unified, programmable environment, aiming to accelerate research cycles and improve reproducibility. The company primarily serves biopharma, biotech, and academic institutions seeking to scale their R&D operations without significant capital expenditure in physical infrastructure. By digitizing the experimental workflow, Strateos positions itself as a key enabler for the digital transformation of life sciences.

AI / Machine LearningDrug Discovery

Technology Platform

Cloud-based, software-defined robotic laboratory platform enabling remote design, execution, and data analysis of life science experiments via API/GUI.

Funding History

2
Total raised:$86M
Series B$56M
Series A$30M

Opportunities

The accelerating digital transformation of pharma R&D and the rise of virtual biotechs create strong demand for remote, automated research platforms.
The need for high-quality, structured data to fuel AI-driven drug discovery aligns perfectly with Strateos's automated data capture and management capabilities.

Risk Factors

Key risks include the operational complexity of scaling and maintaining fault-tolerant robotic labs, the cultural challenge of convincing scientists to adopt remote experimentation, and competition from large automation vendors and CROs developing their own integrated solutions.

Competitive Landscape

Strateos competes with large lab automation vendors (e.g., Thermo Fisher, Agilent), traditional contract research organizations (CROs) investing in automation, and a new wave of tech-bio companies. Its primary differentiation is its fully integrated, cloud-native platform and remote-access 'lab as a service' model, unlike point-solution automation or on-premise CRO services.